Results 161 to 170 of about 11,522 (197)

Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective. [PDF]

Front Immunol
Chen Y, Zhang Y, Zhang Y, Bie C, Wang R, Zhao Y, Lu M.   +6 more
europepmc   +1 more source

Going batty: US bat imports raise concerns for species conservation and human health. [PDF]

One Health
Tarango M, Kolby JE, Goodman OLB, Anderson CJ, Tinsman J, Kirkey J, Liew A, Jones M, Firth C, Reaser JK.   +9 more
europepmc   +1 more source

Cross-border transmission corridors and diffusion velocities of Ebola-virus in in the Great-lakes basin: A 1976-2025 multilayered phylogeographic analysis.

GEORGE P, Okware S, Olupot-Olupot P.
europepmc   +1 more source

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches). [PDF]

BMC Med
Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X, Enwere G, Vicari A, Nadlaou SD, Toure A, Sani IM, Diallo A, Kolie C, Duraffour S, Ifono K, Maomou A, Dore K, Djidonou HA, Bagayoko A, Damey PP, Camara MN, Diallo FB, Oumar FT, Toure K, Diaby ML, Sylla L, Conde D, Kaba IL, Tipton T, Eggo RM, Marks M, Roberts CH, Strecker T, Günther S, Keita S, Edmunds WJ, Carroll MW, Henao-Restrepo AM.   +36 more
europepmc   +1 more source

Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding site. [PDF]

iScience
Wang LL, Keiser P, Yang D, Seravalli J, Patten JJ, Eaton B, Anderson D, Liu Y, Holbrook MR, Smith AB, Davey RA, Xiang SH.   +11 more
europepmc   +1 more source

High-resolution ecological niche maps identify population-density hot-spots for Ebola disease spill-over in Uganda.

George P, Okware S, Olupot-Olupot P.
europepmc   +1 more source

Investigating the Sudan virus outbreak in Uganda through the deployment of a mobile laboratory. [PDF]

BMC Infect Dis
Pimundu G, Muyigi T, Nambozo EJ, Okiira C, Kanamwanji B, Nalwanga R, Sekate J, Mugabe R, Naiga J, Sewanyana I, Lutwama J, Balinandi S, Kaleebu P, Aceng JR, Atwiine D, Mwebesa H, Bosa HK, Kagirita A, Olaro C, Nsawotebba A, Achol E, Lagu H, Nzeyimana E, May J, Gehre F, Affara M, Nabadda S.   +26 more
europepmc   +1 more source

Overview of vaccines for adults authorized, recommended, and implemented in the European Union. [PDF]

NPJ Vaccines
Pattyn J, Launay O, Steffen R, Weinberger B, Gabutti G, Ihan A, Weinke T, Jancoriene L, Bonanni P, Van Damme P.   +9 more
europepmc   +1 more source

Exploring the Use of Viral Vectors Pseudotyped with Viral Glycoproteins as Tools to Study Antibody-Mediated Neutralizing Activity. [PDF]

Microorganisms
Ramos-Cela M, Forconi V, Antonelli R, Manenti A, Montomoli E.   +4 more
europepmc   +1 more source

Vaccines for preventing Ebola virus disease. [PDF]

Cochrane Database Syst Rev
Kuehn R, Ryan H, Okwaraeke KC, Gould S, Chaplin M, Riley M, Turtle L, Jacob ST, Fletcher T.   +8 more
europepmc   +1 more source